Table 3 Levels of the prothrombotic markers according to group characteristics of the population
n | D-dimer (ng/mL) | F1 + 2 (pmol/L) | ETP (nM⋅min) | ||
|---|---|---|---|---|---|
Sex | Male | 800 | 424 (275,755) | 238 (175,350) | 1576 (1401,1748) |
Female | 187 | 609 (399,1008) | 287 (203,395) | 1494 (1284,1702) | |
p | 0.001 | 0.001 | 0.001 | ||
Smoking | + | 474 | 448 (275,796) | 245 (179,347) | 1573 (1364,1762) |
- | 513 | 467 (295,795) | 250 (178,382) | 1557 (1368,1726) | |
p | 0.675 | 0.594 | 0.269 | ||
Previous CVD | + | 229 | 484 (286,798) | 244 (177,332) | 1569 (1348,1733) |
- | 758 | 452 (286,796) | 247 (180,369) | 1563 (1370,1745) | |
p | 0.553 | 0.386 | 0.503 | ||
HT | + | 553 | 553 (355,952) | 275 (197,398) | 1563 (1366,1730) |
- | 418 | 418 (273,773) | 235 (174,346) | 1565 (1366,1745) | |
p | 0.001 | 0.001 | 0.381 | ||
Diabetes | + | 870 | 454 (246,848) | 232 (169,324) | 1490 (1261,1754) |
- | 117 | 456 (292,795) | 249 (180,365) | 1572 (1373,1754) | |
p | 0.285 | 0.142 | 0.004 | ||
LVEF (%) | >40 | 147 | 440 (285,755) | 242 (174,363) | 1573 (1371,1735) |
≤40 | 620 | 679 (408,1156) | 297 (189,397) | 1488 (1293,1691) | |
p | <0.001 | 0.016 | 0.017 |